Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BrightSpring Health Services (BTSG) Gains from Investment Securities (2023 - 2025)

BrightSpring Health Services (BTSG) has disclosed Gains from Investment Securities for 3 consecutive years, with $16.2 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities rose 107.04% year-over-year to $16.2 million, compared with a TTM value of $30.5 million through Sep 2025, up 174.16%, and an annual FY2024 reading of $25.0 million, down 33.46% over the prior year.
  • Gains from Investment Securities was $16.2 million for Q3 2025 at BrightSpring Health Services, up from -$1.6 million in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $29.9 million in Q3 2023 and bottomed at -$1.6 million in Q2 2025.
  • Average Gains from Investment Securities over 3 years is $7.0 million, with a median of $1.9 million recorded in 2023.
  • The sharpest move saw Gains from Investment Securities skyrocketed 743.3% in 2024, then crashed 244.05% in 2025.
  • Year by year, Gains from Investment Securities stood at $1.9 million in 2023, then surged by 743.3% to $15.7 million in 2024, then grew by 3.51% to $16.2 million in 2025.
  • Business Quant data shows Gains from Investment Securities for BTSG at $16.2 million in Q3 2025, -$1.6 million in Q2 2025, and $245000.0 in Q1 2025.